SureTrader SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, stockdarockk, bz777, Swiffer, NeverSettle
Search This Board: 
Last Post: 2/23/2017 7:36:47 AM - Followers: 356 - Board type: Free - Posts Today: 5



Arrayit (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.


- Powerful Science for Life™



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection


About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ARYC News: Current Report Filing (8-k) 12/05/2016 04:31:06 PM
ARYC News: Current Report Filing (8-k) 12/05/2016 03:16:26 PM
#41182  Sticky Note SKULL AND CROSSBONES FOR ARYC. lucky,mydog 02/09/17 08:24:37 AM
#41045  Sticky Note Here are the details and DD updates stockzoom 02/08/17 10:32:34 AM
#36387  Sticky Note just a little DD here......... NeverSettle 12/06/16 03:13:42 PM
#34865  Sticky Note All new shareholders, investors, and investment firms please Jimmy Jackson jr 11/23/16 10:23:48 AM
#41822   Yes sir I agree. Great products. GVInvestments 02/23/17 07:36:47 AM
#41821   Aryc is a real company indead but any Hugie 02/23/17 07:35:27 AM
#41820   ARYC can be a great company but none Hugie 02/23/17 07:27:20 AM
#41819   ARYC real company with great product sales in Ken1998 02/23/17 06:34:57 AM
#41818   The haven't signed anything worth anything --- And General_Sevier 02/23/17 01:04:53 AM
#41817   AMAZING BUYING OPPORT TUNNNNEEE ITTTT!!! [/c Herder 02/22/17 11:19:35 PM
#41816   I'm buying. This is a great company. GVInvestments 02/22/17 11:12:15 PM
#41815   Nasomniyak is correct in that book value is Pokerjoe 02/22/17 10:15:59 PM
#41814   Analysts don't give a book value to a nsomniyak 02/22/17 06:52:40 PM
#41811   Totally, it would be karma though! Arrayit, bigdog121 02/22/17 05:06:21 PM
#41810   I agree as well.. would suck for them Buckstopshere 02/22/17 05:04:05 PM
#41809   Yep, agreed! bigdog121 02/22/17 04:54:34 PM
#41808   This is emotional sell by some without patience. Ken1998 02/22/17 04:52:06 PM
#41807   Wow! 13.5 milli...I only have 2 milli but Daniel_777 02/22/17 04:42:39 PM
#41804   They probably have to wait to do more General_Sevier 02/22/17 04:37:03 PM
#41802   Because nobody has any interest in them, nobody General_Sevier 02/22/17 04:35:00 PM
#41800   Confidence comes from common sense... spotlight1 02/22/17 04:34:52 PM
#41798  Restored I agree the company wouldn't withhold the release davidcfield 02/22/17 04:30:02 PM
#41797   IRS is about to come knocking with a General_Sevier 02/22/17 04:29:19 PM
#41795   Their tiny R&D project had to do with General_Sevier 02/22/17 04:28:52 PM
#41794   The Twitter Twit even took to Twitter years General_Sevier 02/22/17 04:28:23 PM
#41793   Now the Twitter Twit is dredging up the General_Sevier 02/22/17 04:27:42 PM
#41792   Seems like the more they tweet the lower EDobbs40 02/22/17 04:04:50 PM
#41791   What, is it easier to say the company techmover 02/22/17 04:04:10 PM
#41790   What gives you such confidence? MikeCr 02/22/17 03:58:20 PM
#41789   ARYC....R.I.G.H.T...O.N...!!!.....G.O..F.O.R..I.T..!!!$$$$$$$$$$$$$$ tm1119 02/22/17 03:57:08 PM
#41788   The company is not holding back the release spotlight1 02/22/17 03:46:02 PM
#41787   So do I but I am going to Hugie 02/22/17 03:16:20 PM
#41786   what reason for big decline today? JB3136 02/22/17 03:14:45 PM
#41785   I just loaded a few more...ARYC$$$$ Daniel_777 02/22/17 02:46:58 PM
#41784   ARYC...HHHMMMMM....COULD.IT.BE.FEB.28.COURT.DATE.??....COULD.BE.... tm1119 02/22/17 02:44:16 PM
#41783   Agreed Mike, Danooo 02/22/17 02:30:13 PM
#41782   Let it, I'll buy in more next month. techmover 02/22/17 02:23:48 PM
#41781   0,0001-0,0004 is coming back Hugie 02/22/17 02:19:27 PM
#41780   Has anyone spoke to them recently and asked dovber26 02/22/17 02:18:36 PM
#41779   I agree, the company needs to release the davidcfield 02/22/17 02:13:14 PM
#41777   90% sells...nobody is buying the ask without fins! jrsh 02/22/17 02:06:56 PM
#41776   Yep doesn't make sense. Looks like some unhappy davidcfield 02/22/17 02:01:22 PM
#41775   wtf is happening today joever 02/22/17 01:53:22 PM
#41774   somebody got their million at .004 joever 02/22/17 01:49:24 PM
#41773   Arrayit maybe slow walking the filing of financials. MikeCr 02/22/17 01:33:52 PM
#41772   NEW...Arrayit advanced Pre-Symptomatic Parkinson's Disease PDx Test newslett Swiffer 02/22/17 12:26:46 PM
#41770   New...Arrayit reports microarray technology sale to top European Swiffer 02/22/17 11:55:20 AM
#41769   NEW...Arrayit sales marketing team invited to $410MM Biotech Swiffer 02/22/17 11:50:43 AM
#41768   NEW...Arrayit reports microarray technology sale to top healthcare Swiffer 02/22/17 11:47:50 AM
#41767   Fair enough - I will refrain from making Delsurfer 02/22/17 11:46:55 AM
#41765   NEW...Arrayit reports $7,5000 microarray technology sale to global Swiffer 02/22/17 11:34:33 AM
#41764   NEW...Arrayit provides technical support top technical specialist healthcare Swiffer 02/22/17 11:32:17 AM
#41763   Maybe if we play the youtube video backwards, Danooo 02/22/17 11:09:49 AM
#41762   Why that Tweet? This is the 3rd Delsurfer 02/22/17 11:02:28 AM